Scale-Up Evaluation Of The HyPerforma DynaDrive S.U.B.s Part 1: ExpiCHO-S Cells And CHO-S Cells (cGMP banked)
Source: Thermo Fisher Scientific
By Jordan Cobia and Ben Madsen, Thermo Fisher Scientific

As a molecule approaches commercial launch and more is known about the potential market demand, companies are often faced with the decision to scale up or scale out their manufacturing processes. Generally, when scale-up production vessels of more than 2,000 L, this decision also involves moving from single-use bioreactors (S.U.B.s) to traditional stainless-steel systems.
VIEW THE APPLICATION NOTE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more